Systematic review and meta-analysis of additional technologies to enhance angioplasty for infrainguinal peripheral arterial occlusive disease

British Journal of Surgery

Volumn 100, Issue 9, 2013, Pages 1128-1137

  Simpson, E L ^a   Michaels, J A ^a   Thomas, S M ^a   Cantrell, A J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ELUTING STENT; HUMAN; INGUINAL CANAL; META ANALYSIS; METHODOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REOPERATION; REVIEW; TREATMENT OUTCOME; VASCULARIZATION;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; DRUG-ELUTING STENTS; HUMANS; INGUINAL CANAL; PERIPHERAL VASCULAR DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REOPERATION; TREATMENT OUTCOME;

EID: 84880095220     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9196     Document Type: Review

References (66)

1. Simpson EL, Kearns B, Stevenson MD, Cantrell AJ, Littlewood C, Michaels JA,. Enhancements to Angioplasty for Peripheral Arterial Occlusive Disease (PAOD): Systematic Review, Cost-Effectiveness Assessment and Expected Value of Information Analysis. HTA Project. National Institute for Health Research Health Technology Assessment. http://www.hta.ac.uk/project/2324.asp [accessed 11 June 2013 ].
2. Centre for Reviews and Dissemination. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care (3rd edn). University of York: York, 2009.
3. The Cochrane Collaboration. Review Manager 5·1. The Nordic Cochrane Centre: Copenhagen, 2011.
4. Moher D, Liberati A, Tetzlaff J, Altman DG,; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269.
5. Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Duber C, et al.; AMS INSIGHT Investigators. AMS INSIGHT-absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009; 32: 424-435.
6. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009; 74: 1090-1095.
7. Greenberg D, Rosenfield K, Garcia LA, Berezin RH, Lavelle T, Fogleman S, et al. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). J Vasc Interv Radiol 2004; 15: 1065-1069.
8. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007; 116: 285-292.
9. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al.; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-276.
10. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007; 115: 2745-2749.
11. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888.
12. Sabeti S, Czerwenka-Wenkstetten A, Dick P, Schlager O, Amighi J, Mlekusch I, et al. Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. J Endovasc Ther 2007; 14: 431-437.
13. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A,. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg 2003; 37: 487-494.
14. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001; 12: 23-31.
15. Grimm J, Müller-Hülsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M,. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001; 12: 935-942.
16. Rand T, Basile A, Cejna M, Fleischmann D, Funovics M, Gschwendtner M, et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol 2006; 29: 29-38.
17. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, van den Bosch HC,. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997; 20: 420-425.
18. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne J, et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 1999; 18: 251-255.
19. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al,. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve month Zilver PTX randomized study results. Circulation 2011; 4: 495-504.
20. Dake M, Ansel G, Jaff M, Ohki T, Saxon R, Smouse HB, et al. Zilver PTX: a prospective, randomized trial of the polymer-free paditaxel-eluting stent compared to balloon angioplasty with provisional bare metal steating in patients with superficial femoral artery disease. Journal of the American College of Cardiology Conference: 22nd Annual Symposium of the Transcatheter Cardiovascular Therapeutics, Washington, 2010.
21. Ansel G,. Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal artery disease: 24-month update. Catheterization and Cardiovascular Interventions Conference, Baltimore, 2011.
22. Dake M, Ansel G, Ragheb A,. Interim report on the Zilver PTX clinical trial. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting, Copenhagen, 2008.
23. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006; 13: 701-710.
24. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002; 106: 1505-1509.
25. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005; 16: 331-338.
26. Rastan A, Tepe G, Krankenberg H, Zahorsky R, Beschorner U, Noory E, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J 2011; 32: 2274-2281.
27. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ,. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-832.
28. Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ,. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003; 14: 303-311.
29. Nakamura S, Conroy RM, Gordon IL, Deutsch LS, Maheswaran B, Antone CS, et al. A randomized trial of transcutaneous extraction atherectomy in femoral arteries: intravascular ultrasound observations. J Clin Ultrasound 1995; 23: 461-471.
30. Vroegindeweij D, Tielbeek AV, Buth J, Schol FP, Hop WC, Landman GH,. Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning. J Vasc Surg 1995; 21: 255-268.
31. Tielbeek AV, Vroegindeweij D, Buth J, Landman GH,. Comparison of balloon angioplasty and Simpson atherectomy for lesions in the femoropopliteal artery: angiographic and clinical results of a prospective randomized trial. J Vasc Interv Radiol 1996; 7: 837-844.
32. Vroegindeweij D, Kemper FJ, Tielbeek AV, Buth J, Landman G,. Recurrence of stenoses following balloon angioplasty and Simpson atherectomy of the femoro-popliteal segment. A randomised comparative 1-year follow-up study using colour flow duplex. Eur J Vasc Surg 1992; 6: 164-171.
33. Amighi J, Schillinger M, Dick P, Schlager O, Sabeti S, Mlekusch W, et al. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates-randomized controlled trial. Radiology 2008; 247: 267-272.
34. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 2008; 248: 297-302.
35. Jahnke T, Mueller-Huelsbeck S, Charalambous N, Trentmann J, Jamili A, Huemme TH, et al. Prospective, randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD study. J Vasc Interv Radiol 2010; 21: 186-194.
36. Spiliopoulos S, Katsanos K, Karnabatidis D, Diamantopoulos A, Kagadis GC, Christeas N, et al. Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol 2010; 33: 929-938.
37. Gallino A, Do DD, Alerci M, Baumgartner I, Cozzi L, Segatto JM, et al. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. J Endovasc Ther 2004; 11: 595-604.
38. Bonvini R, Baumgartner I, Do DD, Alerci M, Segatto JM, Tutta P, et al. Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. J Am Coll Cardiol 2003; 41: 409-412.
39. Diehm N, Silvestro A, Do DD, Greiner R, Triller J, Mahler F, et al. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. J Endovasc Ther 2005; 12: 723-730.
40. Zehnder T, von Briel C, Baumgartner I, Triller J, Greiner R, Mahler F, et al. Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions. J Endovasc Ther 2003; 10: 304-311.
41. Hagenaars T, A Po IF, van Sambeek MR, Coen VL, van Tongeren RB, Gescher FM, et al,. Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study. J Vasc Surg 2002; 36: 318-324.
42. Krueger K, Zaehringer M, Bendel M, Stuetzer H, Strohe D, Nolte M, et al. De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty-angiographic and clinical follow-up in a prospective randomized controlled trial. Radiology 2004; 231: 546-554.
43. Krueger K, Landwehr P, Bendel M, Nolte M, Stuetzer H, Bongartz R, et al. Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial. Radiology 2002; 224: 519-528.
44. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E,. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up-prospective randomized study. Radiology 2006; 240: 878-884.
45. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M, et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000; 102: 2694-2699.
46. Wolfram RM, Budinsky AC, Pokrajac B, Potter R, Minar E,. Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery-the Vienna experience. Radiology 2005; 236: 338-342.
47. Pokrajac B, Pötter R, Wolfram RM, Budinsky AC, Kirisits C, Lileg B, et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol 2005; 74: 3-9.
48. 192Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. Int J Radiat Oncol Biol Phys 2000; 48: 923-931.
49. van Tongeren RB, van Sambeek MR, van Overhagen H, Coen VL, Schmitz PI, Gescher FM, et al. Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA Trial. J Cardiovasc Surg (Torino) 2005; 46: 437-443.
50. Wyttenbach R, Corti R, Alerci M, Cozzi L, Di Valentino M, Segatto JM, et al. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging. Eur J Vasc Endovasc Surg 2007; 34: 416-423.
51. Wyttenbach R, Gallino A, Alerci M, Mahler F, Cozzi L, Di Valentino M, et al. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 2004; 110: 1156-1161.
52. Fritz P, Stein U, Hasslacher C, Zierhut D, Wannenmacher M, Pritsch M,. External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: results of a prospective randomized double-blind study. Int J Radiat Oncol Biol Phys 2004; 59: 815-821.
53. Therasse E, Donath D, Lesperance J, Tardif JC, Guertin MC, Oliva VL, et al. External beam radiation to prevent restenosis after superficial femoral artery balloon angioplasty. Circulation 2005; 111: 3310-3315.
54. Scheinert D, Zeller T, Duda S, Ricke J, Bosiers M,. Six month follow-up from a prospective, randomized trial comparing a paclitaxel-coated balloon catheter to a noncoated balloon catheter in patients with femoropopliteal disease. CardioVascular and Interventional Radiology Conference, Valencia, 2010.
55. Scheinert D, Zeller T, Duda S, Krankenberg H, Ricke J, Bosiers M,. A prospective, multicenter, single blind, randomized, controlled trial comparing the Lutonix catheter vs. standard balloon angioplasty for treatment of femoropopliteal arteries with and without stenting (LEVANT I). Am J Cardiol 1991; 68: 1079-1086.
56. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008; 358: 689-699.
57. Tepe G, Zeller T, Albrecht T, Speck U. Drug-coated balloons for the prevention of restenosis in peripheral arteries: angiographic and clinical two-year follow-up of the Thunder trial. Am J Cardiol 2008; 102: 219i.
58. Tepe G, Zeller T, Albrecht T, Speck U,. Persistent benefit of drug coated balloons for prevention of restenosis in peripheral arteries: angiographic follow-up after 6 and 12 months. Cardiovascular and Interventional Radiological Society of Europe Annual Meeting, Copenhagen, 2008.
59. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008; 118: 1358-1365.
60. Belli AM, Cumberland DC, Procter AE, Welsh CL,. Follow-up of conventional angioplasty versus laser thermal angioplasty for total femoropopliteal artery occlusions: results of a randomized trial. J Vasc Interv Radiol 1991; 2: 485-488.
61. Belli AM, Cumberland DC, Procter AE, Welsh CL,. Total peripheral artery occlusions: conventional versus laser thermal recanalization with a hybrid probe in percutaneous angioplasty-results of a randomized trial. Radiology 1991; 181: 57-60.
62. Fisher CM, Fletcher JP, May J, White GH, Lord RS, Crozier J, et al. No additional benefit from laser in balloon angioplasty of the superficial femoral artery. Eur J Vasc Endovasc Surg 1996; 11: 349-352.
63. Lammer J, Pilger E, Decrinis M, Quehenberger F, Klein GE, Stark G,. Pulsed excimer laser versus continuous-wave Nd:YAG laser versus conventional angioplasty of peripheral arterial occlusions: prospective, controlled, randomised trial. Lancet 1992; 340: 1183-1188.
64. Spies JB, LeQuire MH, Brantley SD, Williams JE, Beckett WC, Mills JL,. Comparison of balloon angioplasty and laser thermal angioplasty in the treatment of femoropopliteal atherosclerotic disease: initial results of a prospective randomized trial. Work in progress. J Vasc Interv Radiol 1990; 1: 39-42.
65. Tobis JM, Conroy R, Deutsch LS, Gordon I, Honye J, Andrews J, et al. Laser-assisted versus mechanical recanalization of femoral arterial occlusions. Am J Cardiol 1991; 68: 1079-1086.
66. National Institute for Health and Clinical Excellence (NICE). Lower Limb Peripheral Arterial Disease: Diagnosis and Management. NICE clinical guideline 147, August 2012. http://www.nice.org.uk/nicemedia/live/13856/60428/60428.pdf [accessed 11 June 2013 ].